Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
US8119599B2 · kind B2 · utility
8Cited by
11References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2007 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | May 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y203/02013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.